Rett syndrome is a rare X-linked dominant disorder caused by a mutation in the MECP2 gene on the X chromosome. The condition, which is almost exclusively found in females, goes unnoticed for the ...

Rett syndrome is a severe neurodevelopmental disorder, which is clinically diagnosed 1 and usually associated with a mutation in the MECP2 gene. 2 The first line of genetic testing involves ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Phenotype–genotype Correlations. Clinical severity does depend on mutation type and position. ... Cite this: Rett Syndrome: From Recognition to Diagnosis to Intervention - Medscape - May 01, 2008.

Rett syndrome is a sporadic disorder (except for a few familial cases) occurring in 1 in 10,000 to 1 in 23,000 girls worldwide. It is associated with profound mental and motor handicap. About 90% ...

David Lieberman, MD, PhD: The true phenotype trial by Acadia Pharmaceutical had 2 co–end points: the RSBQ (the Rett syndrome behavior questionnaire) and the CGI, a clinical global impression of ...

In 1999, a decade-long search for the genetic basis for Rett syndrome succeeded in identifying mutations in the MECP2 gene in girls fulfilling the criteria for the syndrome. This discovery allowed ...

Taysha Gene Therapies' TSHA-102 tackles Rett syndrome’s root cause with its miniMECP2 transgene and scAAV delivery. ... One of them has severe symptoms, while the other has a milder phenotype.

Taysha Gene Therapies has unfurled more data in the developmental disorder Rett syndrome, ... The adult with 52 weeks of follow up, a 20 year old female with the severe phenotype, ...

An expert discusses the current treatment landscape of Rett syndrome including the goals of treatment and ... MECP2 and that would present with a more severe phenotype, whereas ...

NBC correspondent Richard Engel announced that his son Henry, who had been diagnosed with Rett syndrome as an infant, died on August 9. Here's what to know about the disorder.

When the strength of a clinical endpoint lies in its design, challenges arise when measures are chosen simply because they are the best available options. As much of a trial’s success depends on ...